FR941202-0-00032 FR941202-0-00001 34. In §35.310, the introductory text of paragraph (a), and paragraphs (a)(1) and (a)(5) are revised to read as follows: §35.310 Safety instruction. (a) A licensee shall provide radiation safety instruction for all personnel caring for the patient or the human research subject receiving radiopharmaceutical therapy and hospitalized for compliance with §35.75 of this chapter. To satisfy this requirement, the instruction must describe the licensee's procedures for: (1) Patient or human research subject control; * * * * * (5) Notification of the Radiation Safety Officer in case of the patient's or the human research subject's death or medical emergency. * * * * * 35. In §35.315, the introductory text of paragraph (a), and paragraphs (a)(2), (a)(3), (a)(5), (a)(6), (a)(7), and (b) are revised to read as follows: §35.315 Safety precautions. (a) For each patient or human research subject receiving radiopharmaceutical therapy and hospitalized for compliance with §35.75 of this chapter, a licensee shall: * * * * * (2) Post the patient's or the human research subject's door with a ``Radioactive Materials'' sign and note on the door or in the patient's or human research subject's chart where and how long visitors may stay in the patient's or the human research subject's room; (3) Authorize visits by individuals under age 18 only on a case-by-case basis with the approval of the authorized user after consultation with the Radiation Safety Officer; * * * * * (5) Either monitor material and items removed from the patient's or the human research subject's room to determine that their radioactivity cannot be distinguished from the natural background radiation level with a radiation detection survey instrument set on its most sensitive scale and with no interposed shielding, or handle them as radioactive waste. (6) Provide the patient or the human research subject with radiation safety guidance that will help to keep radiation dose to household members and the public as low as reasonably achievable before authorizing release of the patient or the human research subject. (7) Survey the patient's or the human research subject's room and private sanitary facility for removable contamination with a radiation detection survey instrument before assigning another patient or human research subject to the room. The room must not be reassigned until removable contamination is less than 200 disintegrations per minute per 100 square centimeters; and * * * * * (b) A licensee shall notify the Radiation Safety Officer immediately if the patient or the human research subject dies or has a medical emergency.
